Nonetheless, studies emerging over the last decade support the role of IRF5 as a key regulator of inflammation and it was found to be involved in the pathogenesis of several inflammatory or autoimmune diseases including inflammatory bowel disease, rheumatoid arthritis, and systemic lupus erythematosus [50,51,52,53,54]. Here, IRF5 is linked to systemic lupus erythematosus.